Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Yale University

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders; Substance-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000319

NIDA-09803-2

R01DA009803 (U.S. NIH Grant/Contract)

R01-09803-2

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of treating opioid-dependent individuals with buprenorphine on a thrice-weekly schedule compared to daily dosing.

Sex: All

Ages: 21 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.